JAMP TICAGRELOR
Identification of Jamp Ticagrelor
| No description |
Google image searchProduct monograph
Active ingredient
ticagrelor, 60 MG
DIN: 02531798
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 28-MAR-2024
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
- B01AC24 — TICAGRELOR (ATC/DDD)
Reference brand drug: Brilinta
Pharmaceutical standard: PH EUR
